Cardiac Magnetic Resonance

  • Didier Revel
  • David A. Bluemke
Chapter

Abstract

Magnetic resonance (MR) imaging is widely recognized for its ability to provide accurate and reliable assessments of the function and anatomy of the heart and great vessels. With the recent development of more specialized cardiovascular MR scanners, cardiac MR applications have expanded and are now utilized on a routine basis. In this chapter, the technical aspects of MR scanning of the cardiovascular system are outlined followed by brief discussions of its applications to several diseases involving the heart in adults. A separate chapter in this volume specifically covers the use of cardiac MR for the diagnosis of coronary artery disease.

Keywords

Cardiac Magnetic Resonance Right Ventricle Constrictive Pericarditis Cardiac Amyloidosis Magnetic Resonance Scanner 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Hundley WG, Bluemke DA, Finn JP et al (2010) ACCF/ ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55:2614–2662.CrossRefPubMedGoogle Scholar
  2. 2.
    Makkar RR, Smith RR, Cheng K et al (2012) Intracoronary cardio sphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379:895–904.CrossRefPubMedCentralPubMedGoogle Scholar
  3. 3.
    Rokosh G, Ghafghazi S, Bolli R (2013) Mechanisms of stem cell effects: insights from MRI. Minerva Cardioangiol 61:605–616.PubMedGoogle Scholar
  4. 4.
    Grothues F, Smith GC, Moon JC et al (2002) Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90:29–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Bellenger NG, Burgess MI, Ray SG et al (2000) Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 21:1387–1396.CrossRefPubMedGoogle Scholar
  6. 6.
    Reeder SB, Du YP, Lima JA, Bluemke DA (2001) Advanced cardiac MR imaging of ischemic heart disease. Radiographics 21:1047–1074.CrossRefPubMedGoogle Scholar
  7. 7.
    Shehata ML, Cheng S, Osman NF et al (2009) Myocardial tissue tagging with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:55.CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Bottini PB, Carr AA, Prisant LM et al (1995) Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 8:221–228.CrossRefPubMedGoogle Scholar
  9. 9.
    Hundley WG, Bluemke DA, Finn JP et al (2010) ACCF/ACR/ AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 121:2462–2508.CrossRefPubMedGoogle Scholar
  10. 10.
    Davies MJ (2000) The cardiomyopathies: an overview. Heart 83:469–474.CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Nazarian S, Bluemke DA, Lardo AC et al (2005) Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112:2821–2825.CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    Piers SR, Tao Q, van Hüls van Taxis CF et al (2013) Contrastenhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy. Circ Arrhythm Electrophysiol 6:875–883.CrossRefPubMedGoogle Scholar
  13. 13.
    Doltra A, Amundsen BH, Gebker R (2013) Emerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev 9:185–190.CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    Wu KC (2006) Utility of cardiac MRI in the diagnosis of hypertrophic cardiomyopathy. Curr Cardiol Rep 8:41.CrossRefPubMedGoogle Scholar
  15. 15.
    Maron MS, Olivotto I, Harrigan C et al (2011) Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation 124:40–47.CrossRefPubMedGoogle Scholar
  16. 16.
    Ho CY, Sweitzer NK, McDonough B et al (2002) Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105:2992–2997.CrossRefPubMedGoogle Scholar
  17. 17.
    Maron MS (2012) Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 14:13.CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Noureldin RA, Liu S, Nacif MS et al (2012) The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:17.CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Wu KC, Heldman AW, Brinker JA et al (2001) Microvascular obstruction after nonsurgical septal reduction for the treatment of hypertrophic cardiomyopathy. Circulation 104:1868.CrossRefPubMedGoogle Scholar
  20. 20.
    te Riele AS, Tandri H, Bluemke DA (2014) Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update. J Cardiovasc Magn Reson 16:50.CrossRefGoogle Scholar
  21. 21.
    Jain A, Tandri H, Calkins H, Bluemke DA (2008) Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson 10:32.CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Marcus FI, McKenna WJ, Sherrill D et al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121:1533–1541.CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Friedrich MG (2000) Magnetic resonance imaging in cardiomyopathies. J Cardiovasc Magn Reson 2:67–82.CrossRefPubMedGoogle Scholar
  24. 24.
    Schulz-Menger J, Friedrich MG (2000) Magnetic resonance imaging in patients with cardiomyopathies: when and why. Herz 25:384–391.CrossRefPubMedGoogle Scholar
  25. 25.
    Vignaux O (2005) Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184:249–254.CrossRefPubMedGoogle Scholar
  26. 26.
    Tadamura E, Yamamuro M, Kubo S et al (2005) Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185:110–115.CrossRefPubMedGoogle Scholar
  27. 27.
    Penneil DJ, Berdoukas V, Karagiorga M et al (2006) Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 107:3738–3744.CrossRefGoogle Scholar
  28. 28.
    Penneil DJ (2005) T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 1054:373–378.CrossRefGoogle Scholar
  29. 29.
    Carpenter JP, Grasso AE, Porter JB (2013) On myocardial siderosis and left ventricular dysfunction in hemochromatosis. J Cardiovasc Magn Reson 15:24.CrossRefPubMedCentralPubMedGoogle Scholar
  30. 30.
    Maceira AM, Prasad SK, Hawkins PN (2008) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10:54.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Karamitsos TD, Piechnik SK, Banypersad SM et al (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6:488–497.CrossRefPubMedGoogle Scholar
  32. 32.
    Rajiah P (2011) Cardiac MRI: Part 2, pericardial diseases. AJR Am J Roentgenol 197:W621–634.CrossRefPubMedGoogle Scholar
  33. 33.
    Friedrich MG, Sechtem U, Schulz-Menger J et al (2009) Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 53:1475–1487.CrossRefPubMedCentralPubMedGoogle Scholar
  34. 34.
    O’Donnell DH, Abbara S, Chaithiraphan V et al (2009) Cardiac tumors: optimal cardiac MR sequences and spectrum of imaging appearances. AJR Am J Roentgenol 193:377–387.CrossRefPubMedGoogle Scholar
  35. 35.
    Wölk MJ, Bailey SR, Doherty JU et al (2014) ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/ST S 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 63:380–406.CrossRefPubMedGoogle Scholar
  36. 36.
    Nandalur KR, Dwamena BA, Choudhri AF et al (2007) Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 50:1343–1353.CrossRefPubMedGoogle Scholar
  37. 37.
    Lipinski MJ, McVey CM, Berger JS et al (2013) Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol 62:826–838.CrossRefPubMedGoogle Scholar
  38. 38.
    Schwitter J, Wacker CM, Wilke N et al (2013) MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J 34:775–781.CrossRefPubMedGoogle Scholar
  39. 39.
    Shan K, Constantine G, Sivananthan M, Flamm SD (2004) Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation 109:1328–1334.CrossRefPubMedGoogle Scholar
  40. 40.
    Gutberiet M, Fröhlich M, Mehl S et al (2005) Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobut-amine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization. Eur Radiol 15:872–880.CrossRefGoogle Scholar
  41. 41.
    Yonezawa M, Nagata M, Kitagawa K et al (2014) Quantitative analysis of 1.5-T whole-heart coronary MR angiograms obtained with 32-channel cardiac coils: a comparison with conventional quantitative coronary angiography. Radiology 271:356–364.CrossRefPubMedGoogle Scholar
  42. 42.
    Yoon YE, Kitagawa K, Kato S et al (2012) Prognostic value of coronary magnetic resonance angiography for prediction of cardiac events in patients with suspected coronary artery disease. J Am Coll Cardiol 60:2316–2322.CrossRefPubMedGoogle Scholar
  43. 43.
    Sakuma H (2011) Coronary CT versus MR angiography: the role of MR angiography. Radiology 258:340–349.CrossRefPubMedGoogle Scholar
  44. 44.
    Nagata M, Kato S, Kitagawa K et al (2011) Diagnostic accuracy of 1.5-T unenhanced whole-heart coronary MR angiography performed with 32-channel cardiac coils: initial single-center experience. Radiology 259:384–392.CrossRefPubMedGoogle Scholar
  45. 45.
    Kefer J, Coche E, Legros G et al (2005) Head-to-head comparison of three-dimensional navigator-gated magnetic resonance imaging and 16-slice computed tomography to detect coronary artery stenosis in patients. J Am Coll Cardiol 46:92–100.CrossRefPubMedGoogle Scholar
  46. 46.
    Pouleur AC, le Polain de Waroux JB, Kefer J et al (2008) Direct comparison of whole-heart navigator-gated magnetic resonance coronary angiography and 40- and 64-slice multidetector row computed tomography to detect the coronary artery stenosis in patients scheduled for conventional coronary angiography. Circ Cardiovasc Imaging 1:114–121.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2015

Authors and Affiliations

  • Didier Revel
    • 1
  • David A. Bluemke
    • 2
  1. 1.Department of RadiologyUniversité Claude Bernard Lyon 1BronFrance
  2. 2.Radiology and Imaging SciencesJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations